Azitra, Inc. (AZTR)
NYSEAMERICAN: AZTR · Real-Time Price · USD
0.1513
+0.0026 (1.75%)
At close: Jul 7, 2026, 4:00 PM EDT
0.1420
-0.0093 (-6.15%)
Pre-market: Jul 8, 2026, 8:07 AM EDT
Azitra Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
13
Market Cap
2.45M
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 7.50K | -678.50K | -98.91% |
| Dec 31, 2023 | 686.00K | 402.00K | 141.55% |
| Dec 31, 2022 | 284.00K | 174.00K | 158.18% |
| Dec 31, 2021 | 110.00K | -315.00K | -74.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SciSparc | 856.00K |
| Onconetix | 735.20K |
| VivoSim Labs | 142.00K |
| Biodexa Pharmaceuticals | 104.90K |
| Virax Biolabs Group | 2.99K |
AZTR News
- 21 days ago - Azitra, Inc. CEO Issues Letter to Shareholders Detailing Strategic Reorientation Initiatives and Outlook for 2026 and Beyond - PRNewsWire
- 4 weeks ago - Azitra Announces Adjournment of 2026 Annual Meeting and Information for Reconvened Meeting - PRNewsWire
- 4 weeks ago - Azitra Proxy statement: Proxy filing - Filings
- 5 weeks ago - Azitra Announces Intention to Adjourn Annual Meeting and Reconvene Annual Meeting - PRNewsWire
- 6 weeks ago - Azitra Proxy statement: Proxy filing - Filings
- 6 weeks ago - Azitra files to sell 255.7M shares of common stock for holders - TheFly
- 6 weeks ago - Azitra Registration statement: Registration filing - Filings
- 7 weeks ago - Azitra, Inc. Announces Q1 2026 Results and Provides Business Updates - PRNewsWire